arrow
A

Anna Wesołowska

faculty of pharmacy
H指数:33
被引数:3,829

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Simultaneous modulation of 5-HT6 and SERT by MM394: a dual-target ligand providing neuroprotection against amyloid-β toxicity, memory preservation, and alleviation of BPSD symptoms

MM394对5-HT6和SERT的同时调节:一种双靶点配体,可提供抗淀粉样β毒性、记忆保留和改善BPSD症状的神经保护作用

2025-11-100
PRE
The first-in-class 1,3,5-triazine-derived dual 5-HT6R/FAAH modulators in search for potential drug against neurodegenerative diseases with cognitive impairment

第一类1,3,5-三嗪衍生的双5-HT6R/FAAH调节剂,用于寻找针对伴有认知障碍的神经退行性疾病的潜在药物

2025-08-050
OA
Correction: Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models

更正:化合物PZ-1262,一种Brexpiprazole的4-异喹啉磺酰胺类似物,在啮齿动物模型中产生潜在的抗抑郁、抗焦虑和促认知作用。

2025-05-300
PREAI
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease
2024-01-089
OAAI
Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents
2023-11-011
OAAI
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
2023-11-018
OAAI
Multifunctional Arylsulfone and Arylsulfonamide-Based Ligands with Prominent Mood-Modulating Activity and Benign Safety Profile, Targeting Neuropsychiatric Symptoms of Dementia
2021-08-2613
OAAI
Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1,3,5-triazine derivatives with procognitive properties in vivo
2020-10-0119
OAAI